Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data

PaperCitations, authors & open-access status

Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 10 citations, 2021 year and diamond oa status.

10
Citations
2021
Year
diamond
OA Status

Related on ScholarIQ

Omer Zaidi
Author
Journal of Medical Economics
Journal
Neutropenia and Cancer Infections
Topic
Neutropenia and Cancer Infections
Topic
Biosimilars and Bioanalytical Methods
Topic
Blood disorders and treatments
Topic
470M+ articles · free account